Video

The Role of Potassium-Binding Agents in Treating Hyperkalemia

Conference|ASN Kidney Week - American Society of Nephrology Kidney Week

Dr. Cary Boyd-Shiwarski explained the effectiveness of potassium-binding agents in treating hyperkalemia in resistant hypertension and CKD.

Pharmacy Times spoke to Dr. Cary Boyd-Shiwarski about her session at the ASN 2021 conference titled "Mechanisms of Potassium Handling in CKD."

Boyd explained the effectiveness of potassium-binding agents in treating hyperkalemia in resistant hypertension and CKD.

Related Videos
Related Content
H5N1 vaccine vial | Image Credit: © syhin_stas - stock.adobe.com
January 20th 2025

US Department of Health and Human Services Grants $590 Million to Accelerate H5N1 mRNA Vaccine Development

Alexandra Gerlach, Associate Editor
Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting
December 23rd 2024

Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting

Alexandra Gerlach, Associate Editor
Nurse preparing dextrose infusion | Image Credit: © Sherry Young - stock.adobe.com
January 20th 2025

Managing Cancer Treatment Amid a Nationwide IV Fluid Shortage

Alexandra Gerlach, Associate Editor
Pharmacy Focus: The Role of Pharmacists in Promoting Mental Health Care
June 7th 2024

Pharmacy Focus: The Role of Pharmacists in Promoting Mental Health Care

Woman holding pink breast cancer awareness ribbon -- Image credit: marina_li_1 | stock.adobe.com
January 20th 2025

From Abemaciclib to Trastuzumab Deruxtecan: Highlights From the 2024 San Antonio Breast Cancer Symposium

Douglas Braun, PharmD, RPh, CPH, CSP
Medical model of chronic kidney disease -- Image credit: kanruthai | stock.adobe.com
January 20th 2025

Study Shows Potential Population-Level Benefits of Intensive BP Targets in Adults With CKD

Gillian McGovern, Associate Editor